Myelodysplastic Syndrome; Mds

Incidence and onset information

Alternative names

Myelodysplastic Syndrome; Mds Is also known as myelodysplastic syndrome, susceptibility to, included.

Researches and researchers

Doctors, researchs, and experts related to Myelodysplastic Syndrome; Mds extracted from public data.

Myelodysplastic Syndrome; Mds Experts map

Current Researchs and researchers

• DRESDEN — Dr Martin WERMKE

  Principal investigator of clinical trial - Investigator of research project
  
  

  • Institution/s:
    — Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus an der TU Dresden
  • Research area/topic::
    

    ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial: Assessment of body, liver and labile plasma iron and their association with outcome and immunological recovery in Myelodysplastic syndromes or Acute Myeloid Leukemia patients undergoing allogeneic stem cell transplantation



• MANNHEIM — Dr Susanne SAUßELE

  Coordinator of expert centre - Clinical expert - Principal investigator of clinical trial - Investigator of research project - Coordinator of research network
  
  

  • Institution/s:
    — III. Medizinische Universitäts-Klinik, Universitätsklinikum Mannheim
    — Universitätsmedizin Mannheim
  • Research area/topic::
    

    Competence Network 'acute and chronic leukemias'



• MANNHEIM — Pr Rüdiger HEHLMANN

  Principal investigator of clinical trial - Investigator of research project - Coordinator of research network - Director of department
  
  

  • Institution/s:
    — III. Medizinische Universitäts-Klinik, Universitätsklinikum Mannheim
    — Universitätsklinikum Mannheim
  • Research area/topic::
    

    EUROPEAN LEUKEMIA NET: Strengthen and develop scientific and technological excellence in research and therapy of leukemia (coordination)



• ULM — Pr Hartmut DÖHNER

  Coordinator of expert centre - Principal investigator of clinical trial - Investigator of research project
  
  

  • Institution/s:
    — Universitätsklinikum Ulm am Oberen Eselsberg
    — Integratives Tumorzentrum des Universitätsklinikums Ulm
  • Research area/topic::
    

    AMLSG BIO: Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms, and Higher Risk Myelodysplastic Syndrome - The Biology and Outcome (BiO)-Project



• HUDDINGE — Pr Eva HELLSTRÖM-LINDBERG

  Clinical expert - Investigator of research project
  
  

  • Institution/s:
    — Karolinska Universitetssjukhuset - Solna
    — Karolinska Institutet, Karolinska Institutet - Huddinge
  • Research area/topic::
    

    Molecular pathogenesis in myelodysplastic syndromes and acute myeloid leukemia



• STOCKHOLM — Pr Eva HELLSTRÖM-LINDBERG

  Clinical expert - Investigator of research project
  
  

  • Institution/s:
    — Karolinska Universitetssjukhuset - Solna
    — Karolinska Institutet, Karolinska Institutet - Huddinge
  • Research area/topic::
    

    Molecular pathogenesis in myelodysplastic syndromes and acute myeloid leukemia

Myelodysplastic Syndrome; Mds Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Detection by FISH of RPN1/MECOM (inv/t(3)). By CGC Genetics (Portugal). RPN1, MECOM Specificity 50 % Genes 20 %
Thrombocytopenia Sequencing Panel with CNV Detection - Expanded. By PreventionGenetics PreventionGenetics (United States). RUNX1, WAS, ADAMTS13, ABCG5, ABCG8, TUBB1, ACTN1, CD36, MASTL, CYCS, ANKRD26, NBEAL2, ETV6, MECOM, FLI1, FLNA, FYB1, GATA1, GFI1B, GP1BA , (...) View the complete list with 9 more genes Panel complete gene list RUNX1, WAS, ADAMTS13, ABCG5, ABCG8, TUBB1, ACTN1, CD36, MASTL, CYCS, ANKRD26, NBEAL2, ETV6, MECOM, FLI1, FLNA, FYB1, GATA1, GFI1B, GP1BA, GP1BB, GP9, HOXA11, ITGA2B, ITGB3, MPL, MYH9, PRKACG, RBM8A Close Specificity 4 % Genes 20 %
Thrombocytopenia NGS Panel. By Connective Tissue Gene Tests (United States). RUNX1, SMPD1, SRC, TBXAS1, WAS, WIPF1, ADAMTS13, TUBB1, MASTL, LYST, CYCS, ANKRD26, NBEAL2, SLFN14, ETV6, MECOM, FLI1, FYB1, GATA1, GBA , (...) View the complete list with 8 more genes Panel complete gene list RUNX1, SMPD1, SRC, TBXAS1, WAS, WIPF1, ADAMTS13, TUBB1, MASTL, LYST, CYCS, ANKRD26, NBEAL2, SLFN14, ETV6, MECOM, FLI1, FYB1, GATA1, GBA, HOXA11, AP3B1, ITGA2B, ITGB3, MPL, MYH9, PRKACG, RBM8A Close Specificity 4 % Genes 20 %
Thrombocytopenia Deletion / Duplication Panel. By Connective Tissue Gene Tests (United States). RUNX1, SMPD1, SRC, TBXAS1, WAS, WIPF1, ADAMTS13, TUBB1, MASTL, LYST, CYCS, ANKRD26, NBEAL2, SLFN14, ETV6, MECOM, FLI1, FYB1, GATA1, GBA , (...) View the complete list with 8 more genes Panel complete gene list RUNX1, SMPD1, SRC, TBXAS1, WAS, WIPF1, ADAMTS13, TUBB1, MASTL, LYST, CYCS, ANKRD26, NBEAL2, SLFN14, ETV6, MECOM, FLI1, FYB1, GATA1, GBA, HOXA11, AP3B1, ITGA2B, ITGB3, MPL, MYH9, PRKACG, RBM8A Close Specificity 4 % Genes 20 %
Thrombocytopenia Comprehensive Panel. By Connective Tissue Gene Tests (United States). RUNX1, SMPD1, SRC, TBXAS1, WAS, WIPF1, ADAMTS13, TUBB1, MASTL, LYST, CYCS, ANKRD26, NBEAL2, SLFN14, ETV6, MECOM, FLI1, FYB1, GATA1, GBA , (...) View the complete list with 8 more genes Panel complete gene list RUNX1, SMPD1, SRC, TBXAS1, WAS, WIPF1, ADAMTS13, TUBB1, MASTL, LYST, CYCS, ANKRD26, NBEAL2, SLFN14, ETV6, MECOM, FLI1, FYB1, GATA1, GBA, HOXA11, AP3B1, ITGA2B, ITGB3, MPL, MYH9, PRKACG, RBM8A Close Specificity 4 % Genes 20 %
Fluorescent in situ Hybridization - Hematopathology. By Hartford Hospital Laboratory - Molecular Genetics and Cytogenetics Hartford Hospital-Hartford-CT-USA (United States). BCL6, BCR, RUNX1, ABI1, TCF3, TP53, DLEU1, CRLF2, RUNX1T1, CBFB, CDKN2A, CDKN2C, CKS1B, ETV6, MECOM, FGFR1, IGH, JAK2, MYC, ABL1 , (...) View the complete list with 7 more genes Panel complete gene list BCL6, BCR, RUNX1, ABI1, TCF3, TP53, DLEU1, CRLF2, RUNX1T1, CBFB, CDKN2A, CDKN2C, CKS1B, ETV6, MECOM, FGFR1, IGH, JAK2, MYC, ABL1, ATM, PBX1, PDGFRA, PDGFRB, PML, RARA, RB1 Close Specificity 4 % Genes 20 %
FISH, MDS Panel. By Cytogenetics and Molecular Pathology Laboratory UP Health System Marquette (United States). EGR1, MECOM, MYBL2, PTPRT Specificity 25 % Genes 20 %
MECOM. By Fulgent Genetics Fulgent Genetics (United States). MECOM Specificity 100 % Genes 20 %

Sources and references

You can check the following sources for additional information.

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like UROFACIAL SYNDROME 2; UFS2 RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2; RUSAT2 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC ISOLATED OXYCEPHALY